Ichthyosis Clinical Trials

A listing of Ichthyosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17 clinical trials
None
Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)

Aim More insight in pathogenesis of IBS and IBD. Samples are collected in context of an European research project.

colitis
ulcerative colitis
bowel dysfunction
crohn's disease
  • 35 views
  • 21 Jan, 2021
None
Therapeutic Education Using an Internet Application in Hereditary Ichthyosis

The main purpose is to evaluate the feasibility (global use) of a therapeutic patient education program using a specific web application in patients with hereditary ichthyosis.

  • 182 views
  • 24 Jan, 2021
None
An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses

The ichthyoses are a group of lifelong genetic disorders that share characteristics of generalized skin thickening, scaling and underlying cutaneous inflammation. The vast majority are orphan

  • 10 views
  • 16 Apr, 2021
  • 1 location
None
  • 0 views
  • 18 Sep, 2021
  • 7 locations
None
Optimization of Transcutaneous Electrical Acustimulation Modalities for Treatment of IBS-C

This study aims to determine the most effective treatment with Transcutaneous Electrical Acustimulation (TEA) for Irritable Bowel Syndrome with Constipation (IBS-C) by comparing efficacy between 5 separate sessions. The rectum pressure as measured by a device called a barostat will be compared between visits. Each session will be testing a …

abdominal pain
constipation
irritable bowel syndrome
  • 0 views
  • 10 Oct, 2021
  • 1 location
None
Mechanism of PERK - eIF2a Pathways in Intestinal Mucosal Barrier of IBS-D and the Role "Metabolism Ingredients" of Tongxieyaofang

Diarrhea irritable bowel syndrome(IBS-Dhas seriously affected health and quality of life of patients.It may be important pathogenesis in development and recurrence of the process of IBS-D,excessive endoplasmic reticulum stress (ERS) activated PERK(proteinkinaseR-like ERkinasePERK)-eIF2a(eukaryotic translation initiation factor 2 alpha,eIF2a) pathway and damaged intestinal mucosal epithelial Barrier. Tongxieyaofang(TXYF) had obtained satisfactory effect …

diarrhea
  • 1 views
  • 23 Jan, 2021
  • 1 location
None
  • 0 views
  • 17 Aug, 2021
  • 1 location
None
Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children Adolescent and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes The 3CI Study

This phase Ib trial investigates the side effects of the combination of nivolumab and ipilimumab, and to see how well they work in treating patients with cancers that have come back (relapsed) or does not respond to treatment (refractory) and have an increased number of genetic changes. Immunotherapy with monoclonal …

monoclonal protein
lymphoma
platelet count
total body irradiation
monoclonal antibodies
  • 0 views
  • 28 Nov, 2021
  • 5 locations
None
Rice Ceramide Supplementation and Skin Health

Ceramides have been added to newer cosmetic products to improve skin barrier function and exogenously replenish skin ceramides. Of the stratum corneum intercellular lipids, Ceramides are the most effective at restoring barrier function and increasing skin hydration. Different ceramides have been incorporated into cosmetic formulations, but understanding the differences between …

Accepts healthy volunteers
  • 0 views
  • 10 Nov, 2021
  • 2 locations
None
Trastuzumab to Patients With Advanced Gastric Cancer With HER2 Positive Expression in CTC

BACKGROUND: Gastric cancer is one of the most common cancers and is one of the most deadly cancers. Most patients have advanced disease and should receive first-line trastuzumab-associated chemotherapy when the biopsy is positive for immunocytochemical expression and / or HER2 gene amplification. A study conducted by our group noted …

  • 0 views
  • 03 Feb, 2021
  • 1 location